We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSP icon
1351
Inspire Medical Systems
INSP
$1.74B
– –
-800
Closed -$45K
INTC icon
1352
Intel
INTC
$513B
– –
-512,808
Closed -$27.5M
IPAR icon
1353
Interparfums
IPAR
$3.94B
– –
-1,795
Closed -$136K
IRT icon
1354
Independence Realty Trust
IRT
$4.07B
– –
-100
Closed -$1K
ITGR icon
1355
Integer Holdings
ITGR
$4.26B
– –
-897
Closed -$68K
IVZ icon
1356
Invesco
IVZ
$13.9B
– –
-41,623
Closed -$804K
JAZZ icon
1357
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-37,681
Closed -$5.39M
JBGS
1358
JBG SMITH
JBGS
$708M
– –
-1,000
Closed -$41K
JBHT icon
1359
JB Hunt Transport Services
JBHT
$25.2B
– –
-792
Closed -$80K
JELD icon
1360
JELD-WEN Holding
JELD
$164M
– –
-22,314
Closed -$394K
JHG
1361
DELISTED
Janus Henderson
JHG
– –
-4,238
Closed -$106K
JILL icon
1362
J. Jill
JILL
$283M
– –
-280
Closed -$8K
JLL icon
1363
Jones Lang LaSalle
JLL
$16.7B
– –
-11,337
Closed -$1.75M
JOE icon
1364
St. Joe Company
JOE
$3.83B
– –
-20,616
Closed -$340K
JWN
1365
DELISTED
Nordstrom
JWN
– –
-5,500
Closed -$244K
JYNT icon
1366
The Joint Corp
JYNT
$119M
– –
-2,959
Closed -$47K
KAI icon
1367
Kadant
KAI
$3.99B
– –
-3,854
Closed -$339K
KALV
1368
DELISTED
KalVista Pharmaceuticals
KALV
– –
-6,126
Closed -$175K
KB icon
1369
KB Financial Group
KB
$43.5B
– –
-2,313
Closed -$86K
KBR icon
1370
KBR
KBR
$4.8B
– –
-100
Closed -$2K
KEP icon
1371
Korea Electric Power
KEP
$16B
– –
-1
Closed –
KIM icon
1372
Kimco Realty
KIM
$16.4B
– –
-5,800
Closed -$107K
KLIC icon
1373
Kulicke & Soffa
KLIC
$4.78B
– –
-5,979
Closed -$132K
KN icon
1374
Knowles
KN
$3.34B
– –
-1,400
Closed -$25K
KOD icon
1375
Kodiak Sciences
KOD
$2.84B
– –
-11,109
Closed -$73K
53 54
55
56 57

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.